尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the detailed record of transactions filed by Baltimore David. Insider active across 1 company, notably Regulus Therapeutics Inc.. In total, 4 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €20k. Activity tracked since 30 January 2025. The latest transaction was disclosed on 30 April 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
BALTIMORE DAVID is a Director of Regulus Therapeutics Inc. (XNAS). He has 4 filings in total, and among the sampled recent filings, the period runs from 2025-01-31 to 2025-06-27, with EUR 19939 of buys and EUR 0 of sells, and the modal transaction nature is Attribution.